July 3, 2026
A new market report from Credence Research puts a number on something the optical industry across the continent has felt building for years. Africa’s eyewear market is projected to grow from just under 9.93 billion US dollars in 2024 to roughly 19.59 billion by 2032, expanding at a compound annual growth rate of 8.26%. That’s close to doubling in eight years.
The headline number is encouraging on its own. What’s more useful, if you actually operate in this industry, is what the report identifies as the two forces that will decide who captures that growth and who gets squeezed by it: affordability, and where the products themselves come from.
Prescription Glasses Are Driving the Market, Not Fashion
Contrary to what eyewear coverage often assumes, this growth isn’t primarily a fashion or lifestyle story. Prescription glasses led every other product category in 2024, holding an estimated 46.8% share of the market, ahead of sunglasses and contact lenses combined. That share reflects something the report states plainly: a large unmet need for basic vision correction across the continent, with eye examinations and diagnosis rates still climbing from a low base.
Price sensitivity shapes the market just as strongly. Products priced up to 150 US dollars captured 58.4% of total spending in 2024, the largest single price band by a wide margin. The report attributes this to broad adoption of basic prescription glasses among price-conscious consumers, alongside growing use of local assembly and lower-cost frame production to keep entry-level products affordable. This is a market being built from the bottom, on volume and accessibility, not from the top on premium positioning.
Where East Africa Sits in the Picture
Regionally, North Africa currently leads with 27.8% of the continental market, followed by South Africa at 24.3%, both benefiting from more developed retail infrastructure and higher urbanisation. East Africa, the region that includes Kenya, Ethiopia, and Tanzania, holds a 15.4% share.
The report describes East Africa as an emerging market supported by improving healthcare access and expanding urban populations, with steady adoption of prescription eyewear as diagnosis rates and access to optometry services grow. It also notes something that will sound familiar to anyone selling lenses in this region: demand remains largely price-sensitive, with mid-range and affordable eyewear dominating, and retail infrastructure still developing through a mix of independent optical stores and international entrants moving into key cities.
That combination, rising demand plus a market that still runs on affordability, is exactly the environment where the source of a lens matters as much as its quality.
The Two Forces the Report Names as the Real Constraints
Buried in the report’s challenges section are two structural problems that anyone building an optical business in East Africa will recognise immediately.
The first is straightforward: affordability constraints and fragmented access limit conversion. Many consumers still prioritise immediate household needs over preventive eye care, and even when a vision problem is recognised, the purchase of glasses gets delayed. Modern optical retail stays concentrated in major cities, while rural areas depend on informal channels or limited clinical supply, which slows replacement cycles and pushes people toward low-cost, unbranded products that squeeze the formal sector’s margins.
The second is the one that shapes almost everything upstream of the consumer: import dependence and supply chain volatility. The report is direct about this. Many market participants remain dependent on imported frames, lenses, and lens-processing inputs, which leaves pricing vulnerable to currency movements, shipping costs, and customs delays. Long lead times complicate inventory planning, cause stockouts on fast-moving products, and weaken fulfilment on prescription orders specifically, the exact category driving nearly half the market’s revenue.
Those two constraints reinforce each other. A market built on affordability cannot absorb the cost of long, import-dependent supply chains without either raising prices past what consumers can pay, or squeezing margins to a point that makes the business unsustainable.
What the Report Points To as the Way Through
Encouragingly, the report doesn’t stop at naming the problem. Under its opportunities section, it points directly at the solution: localised sourcing and private-label development can widen margins. Companies that shorten supply chains, source regionally where feasible, and finish lenses closer to demand centres can reduce lead times and improve pricing flexibility, particularly in the sub-150 dollar segment that currently accounts for more than half of all spending.
That is a precise description of what Afrilens was built to do. As East Africa’s first advanced ophthalmic lens manufacturing facility, built in partnership with Schneider Optical technology, we produce precision lenses in Kenya, for the Kenyan and wider East African market, without the currency exposure, international shipping timelines, or customs clearance delays that come with sourcing lenses from overseas. We hold ready stock across our core product ranges specifically because the report’s own findings confirm what we already see in daily practice: stockouts on fast-moving prescription SKUs are one of the clearest ways this market loses conversions it should be winning.
The report also flags an untapped opportunity in rural and secondary city markets, where large populations still face limited access to eye testing, qualified opticians, and affordable prescription products. Reaching those areas reliably depends on the same thing that reaching Nairobi opticians depends on: a manufacturer close enough to the market to replenish stock quickly and price consistently, rather than one working around six to ten week shipping windows from another continent.
A Market Worth Building For, Not Just Watching Grow
An 8.26% compound annual growth rate over eight years is a meaningful number, but growth rates on a report don’t automatically translate into a stronger optical sector on the ground in Kenya. They translate into opportunity for whichever businesses are structurally positioned to serve the market as it actually behaves: price-sensitive, prescription-led, and increasingly frustrated by the cost and unreliability of import-dependent supply chains.
East Africa’s 15.4% share of a market heading toward 19.59 billion dollars by 2032 represents real, substantial demand. Capturing a fair share of that growth, for opticians and for the patients they serve, will depend less on the region’s overall trajectory and more on whether the lenses reaching Kenyan shelves come from a supply chain built for this market, rather than one simply passing through it.
Afrilens is East Africa’s first advanced ophthalmic lens manufacturing facility, built in partnership with Schneider Optical technology. We currently supply independent opticians, retail chains, hospitals, and NGOs across Kenya, with plans to expand across East and Central Africa in the coming years.
